Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg | ST GLIPTIN GM 50+1000+1

Description

ST GLIPTIN GM 50+1000+1 is a highly effective oral antidiabetic medication formulated with a triple combination of Sitagliptin Phosphate Monohydrate (64.25 mg, equivalent to Sitagliptin 50 mg), Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This unique formulation is designed to provide comprehensive blood sugar control in patients with Type 2 Diabetes Mellitus (T2DM) who are unable to achieve adequate glycemic control with single or dual therapy. Manufactured under stringent quality standards by Steris Healthcare, ST GLIPTIN GM 50+1000+1 offers a synergistic action that targets multiple mechanisms of glucose regulation—improving insulin sensitivity, enhancing insulin secretion, and reducing hepatic glucose output. Uses of ST GLIPTIN GM 50+1000+1 ST GLIPTIN GM 50+1000+1 is primarily used for: Management of Type 2 Diabetes Mellitus It helps to maintain blood glucose levels within normal range by combining the benefits of three proven antidiabetic agents. Reducing the risk of diabetes-related complications By maintaining better glycemic control, it helps reduce long-term complications such as neuropathy, nephropathy, and retinopathy. Improving insulin function It enhances insulin release and sensitivity, promoting better utilization of glucose by the body. Benefits of ST GLIPTIN GM 50+1000+1 1. Triple-Action Formula for Maximum Glycemic Control Each component of ST GLIPTIN GM 50+1000+1 works through a distinct yet complementary mechanism: Sitagliptin (a DPP-4 inhibitor) increases incretin levels, which stimulate insulin release and decrease glucagon levels when glucose levels are high. Metformin (a biguanide) decreases glucose production by the liver and improves insulin sensitivity. Glimepiride (a sulfonylurea) increases pancreatic insulin secretion to reduce blood sugar. This triple-action therapy offers comprehensive blood sugar control throughout the day. 2. Helps Maintain Long-Term Glycemic Stability The combination helps stabilize fasting and post-meal blood sugar levels, minimizing fluctuations and reducing HbA1c levels effectively. 3. Convenient Once-Daily Dosage ST GLIPTIN GM 50+1000+1 is designed for patient convenience, improving adherence and ensuring consistent therapeutic effects. 4. Weight-Neutral Effect Unlike many antidiabetic medications, the inclusion of Sitagliptin helps minimize weight gain often associated with Glimepiride and other insulin-stimulating agents. 5. Cardiometabolic Benefits By improving insulin sensitivity and lipid profiles, this medicine can support cardiovascular health in diabetic patients. 6. Manufactured by a Trusted Brand – Steris Healthcare Steris Healthcare ensures pharmaceutical excellence, maintaining high standards of purity, efficacy, and safety for every batch of ST GLIPTIN GM 50+1000+1. Dosage and Administration The usual recommended dose of ST GLIPTIN GM 50+1000+1 is one tablet daily, or as prescribed by your healthcare provider. It is best taken with food to reduce the risk of gastrointestinal side effects. The dosage may be adjusted depending on blood sugar levels, renal function, and individual response to treatment. Always follow your doctor’s advice and do not skip or double doses. Missed Dose If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed one and continue your regular schedule. Overdose Overdose may cause severe hypoglycemia (low blood sugar). Seek immediate medical help if you experience sweating, dizziness, or confusion. Side Effects of ST GLIPTIN GM 50+1000+1 Most side effects are mild and temporary, often resolving as the body adjusts to treatment. Common side effects include: Nausea or vomiting Diarrhea or stomach discomfort Headache or dizziness Fatigue or weakness Low blood sugar (especially if taken without food or combined with other antidiabetic drugs) Mild skin rash or itching Serious but Rare Side Effects Severe hypoglycemia Lactic acidosis (a rare but serious complication associated with metformin) Pancreatitis (abdominal pain, nausea, vomiting) Allergic reactions such as swelling or difficulty breathing Consult your doctor immediately if you notice any unusual or severe symptoms. Conclusion ST GLIPTIN GM 50+1000+1 is a powerful triple-combination therapy offering holistic control of Type 2 Diabetes Mellitus. By combining the synergistic effects of Sitagliptin, Metformin, and Glimepiride, it provides robust control of blood sugar levels while minimizing complications and improving quality of life. For patients struggling with fluctuating glucose levels despite dual therapy, ST GLIPTIN GM 50+1000+1 from Steris Healthcare is a trusted, clinically proven solution that supports better glycemic control and long-term health outcomes.